<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Canada’s National Bureau of Economic Research: Patents Harm Poor People (and Help Rich People)</title>
	<atom:link href="http://techrights.org/2009/11/04/canada-on-pharmaceutical-monopoly/feed/" rel="self" type="application/rss+xml" />
	<link>http://techrights.org/2009/11/04/canada-on-pharmaceutical-monopoly/</link>
	<description>Free Software Sentry – watching and reporting maneuvers of those threatened by software freedom</description>
	<lastBuildDate>Tue, 07 Feb 2012 14:00:35 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
	<item>
		<title>By: Roy Schestowitz</title>
		<link>http://techrights.org/2009/11/04/canada-on-pharmaceutical-monopoly/comment-page-1/#comment-75136</link>
		<dc:creator>Roy Schestowitz</dc:creator>
		<pubDate>Wed, 04 Nov 2009 23:41:07 +0000</pubDate>
		<guid isPermaLink="false">http://boycottnovell.com/?p=21156#comment-75136</guid>
		<description>Yes, Microsoft has its share of pet &quot;small inventors&quot;, e.g. Daniel Doll-Steinberg and Tribeka. See &lt;a href=&quot;http://boycottnovell.com/2009/03/27/primer-jonathan-zuck-and-act/&quot; rel=&quot;nofollow&quot;&gt;this post&lt;/a&gt; for details.</description>
		<content:encoded><![CDATA[<p>Yes, Microsoft has its share of pet &#8220;small inventors&#8221;, e.g. Daniel Doll-Steinberg and Tribeka. See <a href="http://boycottnovell.com/2009/03/27/primer-jonathan-zuck-and-act/" rel="nofollow">this post</a> for details.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Jose_X</title>
		<link>http://techrights.org/2009/11/04/canada-on-pharmaceutical-monopoly/comment-page-1/#comment-75133</link>
		<dc:creator>Jose_X</dc:creator>
		<pubDate>Wed, 04 Nov 2009 23:03:44 +0000</pubDate>
		<guid isPermaLink="false">http://boycottnovell.com/?p=21156#comment-75133</guid>
		<description>Some degree of government subsidy can be useful, but a flat rate 20 year monopoly on broadly-scoped software ideas is not very useful to very many and can be used in an extremely stifling manner against the majority and, in particular, against FOSS.</description>
		<content:encoded><![CDATA[<p>Some degree of government subsidy can be useful, but a flat rate 20 year monopoly on broadly-scoped software ideas is not very useful to very many and can be used in an extremely stifling manner against the majority and, in particular, against FOSS.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Jose_X</title>
		<link>http://techrights.org/2009/11/04/canada-on-pharmaceutical-monopoly/comment-page-1/#comment-75132</link>
		<dc:creator>Jose_X</dc:creator>
		<pubDate>Wed, 04 Nov 2009 22:58:13 +0000</pubDate>
		<guid isPermaLink="false">http://boycottnovell.com/?p=21156#comment-75132</guid>
		<description>&gt;&gt; “the introduction of patents in developing countries has not been followed by greater investment.”

The intent is for the big dogs to hold that innovation growth rate down to a manageable level, so patents get introduced.

We see a flourishing of ideas, but the established dogs see threats. They also see a resource, a swelling fountain, whose output needs to be monetized. To pull this off, they need to share some of the spoils with &quot;small inventors&quot;. It puts a lovable face on the filthy patent business.

http://lwn.net/Articles/360428/</description>
		<content:encoded><![CDATA[<p>&gt;&gt; “the introduction of patents in developing countries has not been followed by greater investment.”</p>
<p>The intent is for the big dogs to hold that innovation growth rate down to a manageable level, so patents get introduced.</p>
<p>We see a flourishing of ideas, but the established dogs see threats. They also see a resource, a swelling fountain, whose output needs to be monetized. To pull this off, they need to share some of the spoils with &#8220;small inventors&#8221;. It puts a lovable face on the filthy patent business.</p>
<p><a href="http://lwn.net/Articles/360428/" rel="nofollow">http://lwn.net/Articles/360428/</a></p>
]]></content:encoded>
	</item>
</channel>
</rss>

